• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

田纳西州的医院未遵守 8 项常见实验室检测的价格透明度法规。

Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests.

机构信息

Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, US.

出版信息

Am J Clin Pathol. 2024 Nov 4;162(5):450-454. doi: 10.1093/ajcp/aqae057.

DOI:10.1093/ajcp/aqae057
PMID:38733607
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11532617/
Abstract

OBJECTIVES

The goal of this study was to assess hospital compliance with federal price transparency mandates and barriers to pricing information in Tennessee.

METHODS

All hospitals websites were queried for gross, cash, and BlueCross BlueShield of Tennessee prices for 8 high-frequency laboratory tests in 2 Centers for Medicare & Medicaid Services-mandated pricing sources: (1) a machine-readable file of all available services and (2) a consumer-friendly display of 300 shoppable services. Barriers, including click counts, data availability, and intrahospital price discrepancies, were noted.

RESULTS

Of the 145 Tennessee hospitals assessed, 97.2% were noncompliant with the Centers for Medicare & Medicaid Services final rule. Subanalysis of available machine-readable files, price estimators, and shoppable services files demonstrated 49.6%, 95.1%, and 78.6% noncompliance, respectively. Barriers to pricing information included requiring protected health information (55.9%), missing at least 1 pricing source (7.6%), having no pricing sources available (6.2%), and involving more than 3 clicks to access the cash price in machine-readable files (54.1%) and price estimators (68.6%.) Average intrahospital discrepancy for basic metabolic panel cash prices across pricing sources was $101.30 (range, $0-1012.40).

CONCLUSIONS

Our study showed high levels of noncompliance with price transparency laws, inconsistent and inaccessible pricing, and continued challenges facing patients in Tennessee.

摘要

目的

本研究旨在评估田纳西州医院对联邦价格透明度规定的遵守情况以及定价信息方面存在的障碍。

方法

在 2 个医疗保险和医疗补助服务中心规定的定价来源(1)所有可用服务的机器可读文件和(2)300 种可购物服务的消费者友好型展示中,查询了所有医院网站的 8 项高频实验室检验的总价格、现金价格和田纳西州蓝十字蓝盾价格。注意到障碍,包括点击次数、数据可用性和医院内价格差异。

结果

在所评估的 145 家田纳西州医院中,97.2%不符合医疗保险和医疗补助服务中心的最终规定。对可用的机器可读文件、价格估算器和可购物服务文件的亚组分析分别显示,分别有 49.6%、95.1%和 78.6%不符合规定。定价信息的障碍包括需要保护健康信息(55.9%)、至少缺少 1 个定价来源(7.6%)、没有定价来源可用(6.2%)以及需要超过 3 次点击才能在机器可读文件(54.1%)和价格估算器(68.6%)中访问现金价格。基本代谢面板现金价格在各定价来源之间的平均院内差异为 101.30 美元(范围为 0-1012.40 美元)。

结论

我们的研究表明,田纳西州的医院在价格透明度法规方面存在高度不合规、定价不一致且难以获取的情况,患者仍然面临挑战。

相似文献

1
Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests.田纳西州的医院未遵守 8 项常见实验室检测的价格透明度法规。
Am J Clin Pathol. 2024 Nov 4;162(5):450-454. doi: 10.1093/ajcp/aqae057.
2
Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.不到三分之一的医院提供符合要求的全膝关节置换术价格透明度信息。
Clin Orthop Relat Res. 2022 Dec 1;480(12):2316-2326. doi: 10.1097/CORR.0000000000002288. Epub 2022 Jun 24.
3
Playing by the Rules? Tracking U.S. Hospitals' Responses to Federal Price Transparency Regulation.遵守规则?追踪美国医院对联邦价格透明度法规的回应。
J Healthc Manag. 2024;69(1):45-58. doi: 10.1097/JHM-D-23-00014.
4
Evaluation of Hospital Compliance With Federal Price Transparency Regulations and Variability of Negotiated Rates for Spinal Fusion.评估医院对联邦价格透明度法规的遵守情况以及脊柱融合术议定费率的可变性。
J Am Acad Orthop Surg. 2023 Jul 1;31(13):677-686. doi: 10.5435/JAAOS-D-23-00053. Epub 2023 Apr 3.
5
Not Clearing the Air: Hospital Price Transparency for a Laparoscopic Cholecystectomy.未改善空气质量:腹腔镜胆囊切除术的医院价格透明度。
J Surg Res. 2022 Dec;280:501-509. doi: 10.1016/j.jss.2022.07.037. Epub 2022 Sep 5.
6
Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule.学术医疗中心在实施价格透明度最终规定 1 年后泌尿科手术价格的大幅波动。
JAMA Netw Open. 2023 Jan 3;6(1):e2249581. doi: 10.1001/jamanetworkopen.2022.49581.
7
Investigation of Hospital Pricing Information for Plastic Surgery Procedures Reveals Widespread Violation of the CMS Price Transparency Act.整形手术定价信息调查揭示 CMS 价格透明度法案广泛违规
Plast Reconstr Surg. 2023 Aug 1;152(2):455-462. doi: 10.1097/PRS.0000000000010299. Epub 2023 Feb 15.
8
Provision of Hospital Price Information After Increases in Financial Penalties for Failure to Comply With a US Federal Hospital Price Transparency Rule.违反美国联邦医院价格透明度规定的财务罚款增加后提供医院价格信息。
JAMA Netw Open. 2023 Jun 1;6(6):e2320694. doi: 10.1001/jamanetworkopen.2023.20694.
9
Health Care Price Transparency in Ophthalmology.眼科医疗价格透明度。
JAMA Ophthalmol. 2021 Nov 1;139(11):1210-1216. doi: 10.1001/jamaophthalmol.2021.3951.
10
Evaluating hospital consumer-friendly price-estimator tools for shoppable services within dermatology.评估皮肤科可购物服务的医院消费者友好型价格估算工具。
Arch Dermatol Res. 2023 Aug;315(6):1813-1821. doi: 10.1007/s00403-023-02527-3. Epub 2023 Jan 27.

引用本文的文献

1
Testosterone testing in the United States: limited price transparency and significant variability.美国的睾酮检测:价格透明度有限且差异显著。
Int J Impot Res. 2025 Aug 13. doi: 10.1038/s41443-025-01152-0.
2
Public Awareness and Use of Price Transparency: Report From a National Survey.公众对价格透明度的认知与使用:一项全国性调查的报告
Interact J Med Res. 2024 Dec 12;13:e64439. doi: 10.2196/64439.

本文引用的文献

1
The healthcare price transparency illusion: does anyone know what laboratory tests cost?医疗保健价格透明度幻觉:有人知道实验室检查的费用吗?
J Pediatr. 2024 Jan;264:113755. doi: 10.1016/j.jpeds.2023.113755. Epub 2023 Sep 20.
2
Outpatient apheresis billing: A photopheresis model shows that hospital price transparency data remain difficult to interpret.门诊血液净化治疗计费:光化学疗法模型表明,医院价格透明度数据仍难以解读。
Am J Clin Pathol. 2023 Oct 3;160(4):404-410. doi: 10.1093/ajcp/aqad059.
3
United States blood pricing: A cross-sectional analysis of charges and reimbursement at 200 US hospitals.美国血液定价:200 家美国医院收费和报销情况的横断面分析。
Am J Hematol. 2023 Jul;98(7):E179-E182. doi: 10.1002/ajh.26940. Epub 2023 Apr 25.
4
Estimating the Impact of New Health Price Transparency Policies.评估新的医疗价格透明度政策的影响。
Inquiry. 2023 Jan-Dec;60:469580231155988. doi: 10.1177/00469580231155988.
5
Price Transparency in Hospitals-Current Research and Future Directions.医院价格透明度——当前研究与未来方向
JAMA Netw Open. 2023 Jan 3;6(1):e2249588. doi: 10.1001/jamanetworkopen.2022.49588.
6
Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule.学术医疗中心在实施价格透明度最终规定 1 年后泌尿科手术价格的大幅波动。
JAMA Netw Open. 2023 Jan 3;6(1):e2249581. doi: 10.1001/jamanetworkopen.2022.49581.
7
Demographic Variation in Health Insurance Coverage:United States, 2021.2021年美国医疗保险覆盖情况的人口统计学差异
Natl Health Stat Report. 2022 Nov(177):1-14.
8
Adherence to a Federal Hospital Price Transparency Rule and Associated Financial and Marketplace Factors.遵守联邦医院价格透明度规则及相关财务和市场因素。
JAMA. 2022 Jun 7;327(21):2143-2145. doi: 10.1001/jama.2022.5363.
9
Large variations in hospital pricing for standard procedures revealed.揭示了标准手术定价在医院间的巨大差异。
BMC Res Notes. 2022 Apr 5;15(1):129. doi: 10.1186/s13104-022-06014-2.
10
Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study.与遵守医院价格透明度最终规则相关的因素:一项全国性研究
J Gen Intern Med. 2022 Nov;37(14):3577-3584. doi: 10.1007/s11606-021-07237-y. Epub 2021 Dec 13.